OBJECTIVES: The purpose of this study was to examine prognostic value of T1- and T2-mapping techniques in heart transplant patients. BACKGROUND: Myocardial characterization using T2 mapping (evaluation of edema/inflammation) and pre- and post-gadolinium contrast T1 mapping (calculation of extracellular volume fraction [ECV] for assessment of interstitial expansion/fibrosis) are emerging modalities that have been investigated in various cardiomyopathies. METHODS: A total of 99 heart transplant patients underwent the magnetic resonance imaging (MRI) scans including T1- (n = 90) and T2-mapping (n = 79) techniques. Relevant clinical characteristics, MRI parameters including late gadolinium enhancement (LGE), and invasive hemodynamics were collected. Median clinical follow-up duration after the baseline scan was 2.4 to 3.5 years. Clinical outcomes include cardiac events (cardiac death, myocardial infarction, coronary revascularization, and heart failure hospitalization), noncardiac death and noncardiac hospitalization. RESULTS: Overall, the global native T1, postcontrast T1, ECV, and T2 were 1,030 ± 56 ms, 458 ± 84 ms, 27 ± 4% and 50 ± 4 ms, respectively. Top-tercile-range ECV (ECV >29%) independently predicted adverse clinical outcomes compared with bottom-tercile-range ECV (ECV <25%) (hazard ratio [HR]: 2.87; 95% confidence interval [CI]: 1.07 to 7.68; p = 0.04) in a multivariable model with left ventricular end-systolic volume and LGE. Higher T2 (T2 ≥50.2 ms) independently predicted adverse clinical outcomes (HR: 3.01; 95% CI: 1.39 to 6.54; p = 0.005) after adjustment for left ventricular ejection fraction, left ventricular end-systolic volume, and LGE. Additionally, higher T2 (T2 ≥50.2 ms) also independently predicted cardiac events (HR: 4.92; CI: 1.60 to 15.14; p = 0.005) in a multivariable model with left ventricular ejection fraction. CONCLUSIONS: MRI-derived myocardial ECV and T2 mapping in heart transplant patients were independently associated with cardiac and noncardiac outcomes. Our findings highlight the need for larger prospective studies.
OBJECTIVES: The purpose of this study was to examine prognostic value of T1- and T2-mapping techniques in heart transplant patients. BACKGROUND: Myocardial characterization using T2 mapping (evaluation of edema/inflammation) and pre- and post-gadolinium contrast T1 mapping (calculation of extracellular volume fraction [ECV] for assessment of interstitial expansion/fibrosis) are emerging modalities that have been investigated in various cardiomyopathies. METHODS: A total of 99 heart transplant patients underwent the magnetic resonance imaging (MRI) scans including T1- (n = 90) and T2-mapping (n = 79) techniques. Relevant clinical characteristics, MRI parameters including late gadolinium enhancement (LGE), and invasive hemodynamics were collected. Median clinical follow-up duration after the baseline scan was 2.4 to 3.5 years. Clinical outcomes include cardiac events (cardiac death, myocardial infarction, coronary revascularization, and heart failure hospitalization), noncardiac death and noncardiac hospitalization. RESULTS: Overall, the global native T1, postcontrast T1, ECV, and T2 were 1,030 ± 56 ms, 458 ± 84 ms, 27 ± 4% and 50 ± 4 ms, respectively. Top-tercile-range ECV (ECV >29%) independently predicted adverse clinical outcomes compared with bottom-tercile-range ECV (ECV <25%) (hazard ratio [HR]: 2.87; 95% confidence interval [CI]: 1.07 to 7.68; p = 0.04) in a multivariable model with left ventricular end-systolic volume and LGE. Higher T2 (T2 ≥50.2 ms) independently predicted adverse clinical outcomes (HR: 3.01; 95% CI: 1.39 to 6.54; p = 0.005) after adjustment for left ventricular ejection fraction, left ventricular end-systolic volume, and LGE. Additionally, higher T2 (T2 ≥50.2 ms) also independently predicted cardiac events (HR: 4.92; CI: 1.60 to 15.14; p = 0.005) in a multivariable model with left ventricular ejection fraction. CONCLUSIONS: MRI-derived myocardial ECV and T2 mapping in heart transplant patients were independently associated with cardiac and noncardiac outcomes. Our findings highlight the need for larger prospective studies.
Authors: Maxim Avanesov; Julia Münch; Julius Weinrich; Lennart Well; Dennis Säring; Christian Stehning; Enver Tahir; Sebastian Bohnen; Ulf K Radunski; Kai Muellerleile; Gerhard Adam; Monica Patten; Gunnar Lund Journal: Eur Radiol Date: 2017-06-14 Impact factor: 5.315
Authors: Tushar Kotecha; Ana Martinez-Naharro; Thomas A Treibel; Rohin Francis; Sabrina Nordin; Amna Abdel-Gadir; Daniel S Knight; Giulia Zumbo; Stefania Rosmini; Viviana Maestrini; Heerajnarain Bulluck; Roby D Rakhit; Ashutosh D Wechalekar; Janet Gilbertson; Mary N Sheppard; Peter Kellman; Julian D Gillmore; James C Moon; Philip N Hawkins; Marianna Fontana Journal: J Am Coll Cardiol Date: 2018-06-26 Impact factor: 24.094
Authors: Andrea Di Marco; Ignasi Anguera; Matthias Schmitt; Igor Klem; Tomas G Neilan; James A White; Marek Sramko; Pier Giorgio Masci; Andrea Barison; Peter Mckenna; Ify Mordi; Kristina H Haugaa; Francisco Leyva; Jorge Rodriguez Capitán; Hiroshi Satoh; Takeru Nabeta; Paolo Domenico Dallaglio; Niall G Campbell; Xavier Sabaté; Ángel Cequier Journal: JACC Heart Fail Date: 2016-12-21 Impact factor: 12.035
Authors: James C Moon; Daniel R Messroghli; Peter Kellman; Stefan K Piechnik; Matthew D Robson; Martin Ugander; Peter D Gatehouse; Andrew E Arai; Matthias G Friedrich; Stefan Neubauer; Jeanette Schulz-Menger; Erik B Schelbert Journal: J Cardiovasc Magn Reson Date: 2013-10-14 Impact factor: 5.364
Authors: Maximilian Spieker; Sebastian Haberkorn; Mareike Gastl; Patrick Behm; Stratis Katsianos; Patrick Horn; Christoph Jacoby; Bernhard Schnackenburg; Petra Reinecke; Malte Kelm; Ralf Westenfeld; Florian Bönner Journal: J Cardiovasc Magn Reson Date: 2017-03-29 Impact factor: 5.364
Authors: Frederik H Verbrugge; Philippe B Bertrand; Endry Willems; Ellen Gielen; Wilfried Mullens; Shivraman Giri; W H Wilson Tang; Subha V Raman; David Verhaert Journal: Eur Heart J Cardiovasc Imaging Date: 2017-07-01 Impact factor: 6.875
Authors: Theodoros D Karamitsos; Stefan K Piechnik; Sanjay M Banypersad; Marianna Fontana; Ntobeko B Ntusi; Vanessa M Ferreira; Carol J Whelan; Saul G Myerson; Matthew D Robson; Philip N Hawkins; Stefan Neubauer; James C Moon Journal: JACC Cardiovasc Imaging Date: 2013-03-14
Authors: Marianna Fontana; Silvia Pica; Patricia Reant; Amna Abdel-Gadir; Thomas A Treibel; Sanjay M Banypersad; Viviana Maestrini; William Barcella; Stefania Rosmini; Heerajnarain Bulluck; Rabya H Sayed; Ketna Patel; Shameem Mamhood; Chiara Bucciarelli-Ducci; Carol J Whelan; Anna S Herrey; Helen J Lachmann; Ashutosh D Wechalekar; Charlotte H Manisty; Eric B Schelbert; Peter Kellman; Julian D Gillmore; Philip N Hawkins; James C Moon Journal: Circulation Date: 2015-09-11 Impact factor: 29.690
Authors: Jeffrey M Dendy; Sean G Hughes; Jonathan H Soslow; Daniel E Clark; Cynthia B Paschal; John C Gore Journal: Invest Radiol Date: 2022-04-13 Impact factor: 10.065
Authors: C Sciaccaluga; N Ghionzoli; G E Mandoli; N Sisti; F D'Ascenzi; M Focardi; S Bernazzali; G Vergaro; M Emdin; S Valente; M Cameli Journal: Heart Fail Rev Date: 2021-08-12 Impact factor: 4.654
Authors: Anke Busse; Rengarajan Rajagopal; Seyrani Yücel; Ebba Beller; Alper Öner; Felix Streckenbach; Daniel Cantré; Hüseyin Ince; Marc-André Weber; Felix G Meinel Journal: Radiologe Date: 2020-11 Impact factor: 0.635